CYTRX CORP·4

Dec 17, 2:22 PM ET

KRIEGSMAN STEVEN A 4

4 · CYTRX CORP · Filed Dec 17, 2019

Insider Transaction Report

Form 4
Period: 2019-12-13
KRIEGSMAN STEVEN A
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2019-12-13+3,000,0003,000,000 total
    Exercise: $0.26From: 2019-12-13Exp: 2029-12-12CytRx Common Stock (3,000,000 underlying)

Documents

1 file
  • 4
    ownership.xmlPrimary